To evaluate whether mass administration of azithromycin to infants reduces mortality rates.
Conducted a randomized control trial
Participants were infants aged 1 to 11 months
Mass azithromycin was administered to evaluate its effects
No significant reduction in mortality observed
Findings suggest azithromycin may not be effective in this context
Abstract
The LAKANA trial: a randomized control trial evaluating the impact of mass administration of azithromycin to infants 1 to 11 months of age in Mali showed no reduction in mortality.